◼ Archived
Business
🔮 fades ✓
CNBC
12 independently sourced, verified news trends involving CNBC.
Coverage evidence
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 2 news categories, from Jun 29, 2026 through Nov 8, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
◼ Archived
Business
🔮 holds ✗
CNBC's experts on whether the AI trade is ending and what investors should do next
◼ Archived
Business
🔮 holds ✗
CNBC's The China Connection newsletter: The 'cliff' beneath China's cities
◼ Archived
Business
🔮 holds ✗
CNBC Daily Open: Will America open another front in the Middle East? Trump is considering
◼ Archived
Business
🔮 holds ✗
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
◼ Archived
Business
🔮 fades ✓
Trump admin won't give AI leaders a 'liability shield,' Bessent tells CNBC
◼ Archived
Business
🔮 fades ✓
BOJ expected to hike rates by 25 basis points to fresh three-decade high: CNBC survey
◼ Archived
World
🔮 fades ✓
Saudi pipeline closure is a brief interruption that will last days, U.S. Energy Secretary tells CNBC
◼ Archived
Business
🔮 holds ✗
Disney CEO Josh D'Amaro tells CNBC parks were 'big surprise' in last quarter, company has 'clarity' and 'stability'
Disney’s parks outperformed expectations, yet the CEO warns investors the stock still falls short of confidence.
◼ Archived
Business
🔮 holds ✓
Ohio is America's Top State for Business in 2026, capping yearslong rise with first No. 1 finish
Ohio has claimed the top spot in CNBC's 2026 Top States for Business rankings for the first time following a yearslong rise.
◼ Archived
World
🔮 holds ✗
President Donald Trump defends business dealings, his children in exclusive interview with CNBC
President Donald Trump addresses potential conflicts of interest regarding his family's business dealings in an exclusive interview with CNBC.
◼ Archived
Business
🔮 holds ✗
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
The FDA has launched a new initiative to accelerate the review process for new pharmaceutical manufacturing facilities.